---
category: news
title: "ShapeTX Earns $112 Million Series B"
excerpt: "Seattle biotechnology firm Shape Therapeutics has announced that it generated $112 million from a recent Series B financing round it co-led with Decheng Capital and Breton Capital. The amount is intended to support the companyâ€™s growing portfolio of RNA technologies and accelerate efforts to develop various treatment approaches in the gene therapy field."
publishedDateTime: 2021-07-15T15:15:00Z
originalUrl: "https://www.pharmalive.com/194576-2/"
webUrl: "https://www.pharmalive.com/194576-2/"
type: article
quality: 24
heat: 24
published: false

provider:
  name: PharmaLive
  domain: pharmalive.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.pharmalive.com/wp-content/uploads/2021/07/ShapeTX-Earns-112-Million-Series-B-to-Support-Gene-Therapy-Development-Projects-BioSpace-7-15-21.jpeg"
    width: 625
    height: 350
    isCached: true

secured: "bbnTVizR6jREWfwt3+NKqt0NxaF//mDtT2vqPAO8u4HbZBgx8587hE24xiRtAWJKJFBfB52qNcBtNZrJSqEEa6dBGKJoqY2FTwrTrtn/DMuB4FOXAyHY4JDpU4VaNWXSUPt2eDKSeRUqKKabaVMriRgwbRplvcv2sWbxozjdV8ijEsN7F/eggsD58Fvhz3oeyu9NPFr8ZVw8CXokxb4JITIsheMIokTJU3CdFsXNQXK0gLg5AolCBMEgww5TQYdwxrZpJMdIZxqcaefB5EoXBTy3facTNwju//Df0fsXDlX0efqp9O6J9pMDI98DukNiriBXUHhznYwWZX6KPs6zcMj45iFVWWv1V0i7DIo5rY4=;ld9PWotJan4XQ/R66ZSDKg=="
---

